APO(APO)
APO
Q3 2026 EPS Estimate
$2.21
Aug 4, 2026 · Reports before open
Revenue Estimate
$5.58B
FY2026E EPS$8.93
FY2027E EPS$10.69
Analyst Sentiment
Wall St. Consensus
Buy19 analysts·Moderate coverage
71
Score
16 Buy (84%)3 Hold (16%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1684%
Hold
316%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$142.00
+20.0%
Consensus
$153.50
+29.8%
Bull
$165.00
+39.5%
12-Month Target Range19 analysts
$142.00$153.50$165.00
Current $118.29Consensus
Current Price
$118.29
Upside to Consensus
$35.21
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+15.25%
EPS+19.75%
FY2028
Rev+13.78%
EPS+15.84%
FY2029
Rev-72.11%
EPS+5.22%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $23.04B | $26.55B | $30.21B | $8.43B |
| Low | $22.48B | $25.73B | $29.14B | $8.13B |
| High | $24.03B | $28.14B | $31.46B | $8.77B |
| EBITDA Avg | $7.11B | $8.20B | $9.33B | $2.60B |
| Low | $6.94B | $7.95B | $9.00B | $2.51B |
| High | $7.42B | $8.69B | $9.71B | $2.71B |
| EBIT Avg | $6.41B | $7.39B | $8.40B | $2.34B |
| Low | $6.25B | $7.16B | $8.10B | $2.26B |
| High | $6.68B | $7.83B | $8.75B | $2.44B |
| Net Income Avg | $5.41B | $6.50B | $7.45B | $7.92B |
| Low | $5.25B | $6.22B | $7.14B | $7.56B |
| High | $5.57B | $6.78B | $7.92B | $8.35B |
| EPS Avg | $8.93 | $10.69 | $12.39 | $13.04 |
| Low | $8.63 | $10.24 | $11.75 | $12.43 |
| High | $9.16 | $11.16 | $13.03 | $13.74 |
| Analysts (Rev / EPS) | 5 / 10 | 6 / 10 | 2 / 2 | 5 / 1 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.58B | $5.85B | $6.16B | $6.39B | $6.56B | $6.86B | $7.06B | $7.25B |
| Low | $5.37B | $5.60B | $6.00B | $6.22B | $6.39B | $6.68B | $6.88B | $7.06B |
| High | $5.75B | $6.20B | $6.41B | $6.64B | $6.82B | $7.13B | $7.34B | $7.54B |
| EBITDA Avg | $1.72B | $1.81B | $1.90B | $1.97B | $2.03B | $2.12B | $2.18B | $2.24B |
| Low | $1.66B | $1.73B | $1.85B | $1.92B | $1.97B | $2.06B | $2.12B | $2.18B |
| High | $1.78B | $1.91B | $1.98B | $2.05B | $2.11B | $2.20B | $2.27B | $2.33B |
| EBIT Avg | $1.55B | $1.63B | $1.71B | $1.78B | $1.83B | $1.91B | $1.96B | $2.02B |
| Low | $1.49B | $1.56B | $1.67B | $1.73B | $1.78B | $1.86B | $1.91B | $1.96B |
| High | $1.60B | $1.72B | $1.78B | $1.85B | $1.90B | $1.98B | $2.04B | $2.10B |
| Net Income Avg | $1.31B | $1.38B | $1.47B | $1.48B | $1.55B | $1.63B | $1.71B | $1.71B |
| Low | $1.21B | $1.34B | $1.42B | $1.43B | $1.49B | $1.57B | $1.65B | $1.65B |
| High | $1.40B | $1.44B | $1.55B | $1.56B | $1.63B | $1.71B | $1.80B | $1.80B |
| EPS Avg | $2.20 | $2.32 | $2.47 | $2.49 | $2.60 | $2.74 | $2.87 | $2.88 |
| Low | $2.03 | $2.25 | $2.38 | $2.40 | $2.51 | $2.64 | $2.77 | $2.78 |
| High | $2.36 | $2.43 | $2.60 | $2.62 | $2.74 | $2.88 | $3.02 | $3.03 |
| Analysts (Rev / EPS) | 5 / 12 | 5 / 11 | 2 / 4 | 2 / 4 | 2 / 5 | 2 / 8 | 2 / 4 | 1 / 5 |